After the “cultural turn”, the traditional perspective of Translation Studies (TS) has shifted its emphasis from the language approach to the contextual, ideological, and cultural aspects that ...
PORTLAND, Ore., June 18, 2025--(BUSINESS WIRE)--Diabetomics has been rebranded Modality Dx. Founded by Dr. Srinivasa Nagalla, Modality Dx is an innovator in rapid test technologies for risk assessment ...
SOUTH SAN FRANCISCO, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Verge Genomics, a clinical-stage biotechnology company transforming drug discovery using artificial intelligence and human data, ...
SAN MATEO, Calif.--(BUSINESS WIRE)--Epocrates, Inc., the leading provider of point-of-care reference solutions, today announced it has acquired Modality, Inc., based in Durham, North Carolina.